{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:24:05Z","timestamp":1790029445847,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,5,16]],"date-time":"2010-05-16T00:00:00Z","timestamp":1273968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00296-010-1524-0","type":"journal-article","created":{"date-parts":[[2010,5,15]],"date-time":"2010-05-15T06:39:17Z","timestamp":1273905557000},"page":"1487-1492","source":"Crossref","is-referenced-by-count":93,"title":["Incidence of malignancy in Japanese patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"31","author":[{"given":"Toru","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Momohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,16]]},"reference":[{"key":"1524_CR1","first-page":"62","volume":"29","author":"C Turesson","year":"2002","unstructured":"Turesson C, O\u2019Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2002) Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 29:62\u201367","journal-title":"J Rheumatol"},{"key":"1524_CR2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","volume":"46","author":"A Young","year":"2007","unstructured":"Young A, Koduri G, Batley M et al (2007) Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford) 46:350\u2013357","journal-title":"Rheumatology (Oxford)"},{"key":"1524_CR3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10067-005-0079-z","volume":"25","author":"T Kuroda","year":"2006","unstructured":"Kuroda T, Tanabe N, Harada T et al (2006) Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis. Clin Rheumatol 25:498\u2013505","journal-title":"Clin Rheumatol"},{"key":"1524_CR4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","volume":"52","author":"H Maradit-Kremers","year":"2005","unstructured":"Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722\u2013732","journal-title":"Arthritis Rheum"},{"key":"1524_CR5","first-page":"445","volume":"24","author":"S Wallberg-Jonsson","year":"1997","unstructured":"Wallberg-Jonsson S, Ohman ML, Dahlqvist SR (1997) Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol 24:445\u2013451","journal-title":"J Rheumatol"},{"key":"1524_CR6","first-page":"322","volume":"34","author":"Y Hoshida","year":"2007","unstructured":"Hoshida Y, Xu JX, Fujita S et al (2007) Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34:322\u2013331","journal-title":"J Rheumatol"},{"key":"1524_CR7","first-page":"387","volume":"35","author":"AL Smitten","year":"2008","unstructured":"Smitten AL, Choi HK, Hochberg MC et al (2008) The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol 35:387\u2013393","journal-title":"J Rheumatol"},{"key":"1524_CR8","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar2404","volume":"10","author":"AL Smitten","year":"2008","unstructured":"Smitten AL, Simon TA, Hochberg MC, Suissa S (2008) A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 10:R45","journal-title":"Arthritis Res Ther"},{"key":"1524_CR9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.semarthrit.2007.08.006","volume":"37","author":"L Abasolo","year":"2008","unstructured":"Abasolo L, Judez E, Descalzo MA, Gonzalez-Alvaro I, Jover JA, Carmona L (2008) Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a south European population. Semin Arthritis Rheum 37:388\u2013397","journal-title":"Semin Arthritis Rheum"},{"key":"1524_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.semarthrit.2007.01.002","volume":"37","author":"J Llorca","year":"2007","unstructured":"Llorca J, Lopez-Diaz MJ, Gonzalez-Juanatey C, Ollier WE, Martin J, Gonzalez-Gay MA (2007) Persistent chronic inflammation contributes to the development of cancer in patients with rheumatoid arthritis from a defined population of northwestern Spain. Semin Arthritis Rheum 37:31\u201338","journal-title":"Semin Arthritis Rheum"},{"key":"1524_CR11","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/art.22430","volume":"56","author":"J Franklin","year":"2007","unstructured":"Franklin J, Lunt M, Bunn D, Symmons D, Silman A (2007) Influence of inflammatory polyarthritis on cancer incidence and survival: results from a community-based prospective study. Arthritis Rheum 56:790\u2013798","journal-title":"Arthritis Rheum"},{"key":"1524_CR12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ard.2004.030528","volume":"64","author":"P Geborek","year":"2005","unstructured":"Geborek P, Bladstrom A, Turesson C et al (2005) Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis 64:699\u2013703","journal-title":"Ann Rheum Dis"},{"key":"1524_CR13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.43.2.128","volume":"43","author":"P Prior","year":"1984","unstructured":"Prior P, Symmons DP, Hawkins CF, Scott DL, Brown R (1984) Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis 43:128\u2013131","journal-title":"Ann Rheum Dis"},{"key":"1524_CR14","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/art.1780400906","volume":"40","author":"J Cibere","year":"1997","unstructured":"Cibere J, Sibley J, Haga M (1997) Rheumatoid arthritis and the risk of malignancy. Arthritis Rheum 40:1580\u20131586","journal-title":"Arthritis Rheum"},{"key":"1524_CR15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0049-0172(99)80026-2","volume":"29","author":"P Beauparlant","year":"1999","unstructured":"Beauparlant P, Papp K, Haraoui B (1999) The incidence of cancer associated with the treatment of rheumatoid arthritis. Semin Arthritis Rheum 29:148\u2013158","journal-title":"Semin Arthritis Rheum"},{"key":"1524_CR16","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/ard.2004.033241","volume":"64","author":"J Askling","year":"2005","unstructured":"Askling J, Fored CM, Baecklund E et al (2005) Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 64:1414\u20131420","journal-title":"Ann Rheum Dis"},{"key":"1524_CR17","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.22056","volume":"54","author":"S Setoguchi","year":"2006","unstructured":"Setoguchi S, Solomon DH, Weinblatt ME et al (2006) Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum 54:2757\u20132764","journal-title":"Arthritis Rheum"},{"key":"1524_CR18","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","volume":"32A","author":"L Mellemkjaer","year":"1996","unstructured":"Mellemkjaer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH (1996) Rheumatoid arthritis and cancer risk. Eur J Cancer 32A:1753\u20131757","journal-title":"Eur J Cancer"},{"key":"1524_CR19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","volume":"88","author":"E Thomas","year":"2000","unstructured":"Thomas E, Brewster DH, Black RJ, Macfarlane GJ (2000) Risk of malignancy among patients with rheumatic conditions. Int J Cancer 88:497\u2013502","journal-title":"Int J Cancer"},{"key":"1524_CR20","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0049-0172(97)80023-6","volume":"26","author":"L Georgescu","year":"1997","unstructured":"Georgescu L, Quinn GC, Schwartzman S, Paget SA (1997) Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment. Semin Arthritis Rheum 26:794\u2013804","journal-title":"Semin Arthritis Rheum"},{"key":"1524_CR21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","volume":"54","author":"E Baecklund","year":"2006","unstructured":"Baecklund E, Iliadou A, Askling J et al (2006) Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54:692\u2013701","journal-title":"Arthritis Rheum"},{"key":"1524_CR22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.prp.2006.05.007","volume":"202","author":"M Kojima","year":"2006","unstructured":"Kojima M, Itoh H, Hirabayashi K et al (2006) Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases. Pathol Res Pract 202:679\u2013685","journal-title":"Pathol Res Pract"},{"key":"1524_CR23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10165-008-0031-6","volume":"18","author":"F Shinomiya","year":"2008","unstructured":"Shinomiya F, Mima N, Nanba K et al (2008) Life expectancies of Japanese patients with rheumatoid arthritis: a review of deaths over a 20-year period. Mod Rheumatol 18:165\u2013169","journal-title":"Mod Rheumatol"},{"key":"1524_CR24","doi-asserted-by":"crossref","unstructured":"Nakajima A, Inoue E, Tanaka E, Singh G, Sato E, Hoshi D, Shidara K, Hara M, Momohara S, Taniguchi A, Kamatani N, Yamanaka H (2010) Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand J Rheumatol (in press)","DOI":"10.3109\/03009741003604542"},{"key":"1524_CR25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10165-007-0587-6","volume":"17","author":"H Yamanaka","year":"2007","unstructured":"Yamanaka H, Inoue E, Singh G et al (2007) Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan. Mod Rheumatol 17:283\u2013289","journal-title":"Mod Rheumatol"},{"key":"1524_CR26","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1136\/ard.2005.047274","volume":"65","author":"T Yamada","year":"2006","unstructured":"Yamada T, Nakajima A, Inoue E et al (2006) Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan. Ann Rheum Dis 65:1661\u20131663","journal-title":"Ann Rheum Dis"},{"key":"1524_CR27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10165-006-0475-5","volume":"16","author":"A Nakajima","year":"2006","unstructured":"Nakajima A, Kamitsuji S, Saito A et al (2006) Disability and patient\u2019s appraisal of general health contribute to depressed mood in rheumatoid arthritis in a large clinical study in Japan. Mod Rheumatol 16:151\u2013157","journal-title":"Mod Rheumatol"},{"key":"1524_CR28","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/art.11465","volume":"49","author":"Y Matsuda","year":"2003","unstructured":"Matsuda Y, Singh G, Yamanaka H et al (2003) Validation of a Japanese version of the Stanford health assessment questionnaire in 3, 763 patients with rheumatoid arthritis. Arthritis Rheum 49:784\u2013788","journal-title":"Arthritis Rheum"},{"key":"1524_CR29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/jjco\/hyn074","volume":"38","author":"T Matsuda","year":"2008","unstructured":"Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T (2008) Cancer incidence and incidence rates in Japan in 2002: Based on data from 11 population-based cancer registries. Jpn J Clin Oncol 38:641\u2013648","journal-title":"Jpn J Clin Oncol"},{"key":"1524_CR30","first-page":"1462","volume":"19","author":"SF Kingsmore","year":"1992","unstructured":"Kingsmore SF, Hall BD, Allen NB, Rice JR, Caldwell DS (1992) Association of methotrexate, rheumatoid arthritis and lymphoma: report of 2 cases and literature review. J Rheumatol 19:1462\u20131465","journal-title":"J Rheumatol"},{"key":"1524_CR31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/art.1780390223","volume":"39","author":"TR Bachman","year":"1996","unstructured":"Bachman TR, Sawitzke AD, Perkins SL, Ward JH, Cannon GW (1996) Methotrexate-associated lymphoma in patients with rheumatoid arthritis: report of two cases. Arthritis Rheum 39:325\u2013329","journal-title":"Arthritis Rheum"},{"key":"1524_CR32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ijc.11582","volume":"108","author":"Y Hoshida","year":"2004","unstructured":"Hoshida Y, Tomita Y, Zhiming D et al (2004) Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection. Int J Cancer 108:443\u2013449","journal-title":"Int J Cancer"},{"key":"1524_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-008-9069-8","volume":"26","author":"R Rizzi","year":"2009","unstructured":"Rizzi R, Curci P, Delia M et al (2009) Spontaneous remission of \u201cMethotrexate-associated lymphoproliferative disorders\u201d After discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature. Med Oncol 26:1\u20139","journal-title":"Med Oncol"},{"key":"1524_CR34","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ajh.21003","volume":"82","author":"T Miyazaki","year":"2007","unstructured":"Miyazaki T, Fujimaki K, Shirasugi Y et al (2007) Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection. Am J Hematol 82:1106\u20131109","journal-title":"Am J Hematol"},{"key":"1524_CR35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.lungcan.2007.06.013","volume":"59","author":"S Bernatsky","year":"2008","unstructured":"Bernatsky S, Clarke A, Suissa S (2008) Lung cancer after exposure to disease modifying anti-rheumatic drugs. Lung Cancer 59:266\u2013269","journal-title":"Lung Cancer"},{"key":"1524_CR36","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/art.22579","volume":"56","author":"F Wolfe","year":"2007","unstructured":"Wolfe F, Michaud K (2007) The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19, 562 patients during 89, 710 person-years of observation. Arthritis Rheum 56:1433\u20131439","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1524-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-010-1524-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-010-1524-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:51:56Z","timestamp":1559109116000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-010-1524-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,16]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1524"],"URL":"https:\/\/doi.org\/10.1007\/s00296-010-1524-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,16]]}}}